Ranbaxy Laboratories exclusive launch of generic anti-herpes Valtrex (valacyclovir hydrochloride) tablets in the US will help a listed Indian drug company, Hyderabad-based Avon Organics.

Mumbai-based drugmaker Cipla is in talks with global pharma majors for a drug research and supply agreement, said a top company executive recently.

Pharma company Jubilant Organosys has extended its four-year-old drug research collaboration with Eli Lilly for another five years.Jubilant, through its Bangalore-based subsidiary Jubilant Biosys, had entered into the collaboration with the US-based drugmaker Eli Lilly in late 2005.

BioInvent International AB has entered into a licence and discovery agreement with Daiichi Sankyo Company, Limited for the development of therapeutic antibodies against multiple targets. Under the terms of the collaboration, Daiichi Sankyo will be granted broad access to BioInvent's discovery and development technology platform and in house antibody expertise. As part of the agreement, BioInvent has secured certain co-promotion rights in Scandinavia and the Baltic countries.